These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 22430247)

  • 1. Beyond the Surviving Sepsis Campaign Guidelines: a systematic review of interventions affecting mortality in sepsis.
    Sartini C; Landoni G; Belletti A; Kotani Y; Maimeri N; Umbrello M; Yavorovskiy A; Jabaudon M
    Panminerva Med; 2024 Mar; 66(1):55-62. PubMed ID: 38093626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mortality of patients with sepsis increases in the first month of a new academic year.
    Lee S; Kim S; Ahn S; Cho H; Moon S; Cho YD; Park JH
    Clin Exp Emerg Med; 2024 Jun; 11(2):161-170. PubMed ID: 38286506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on activated protein C (xigris) in the management of sepsis.
    Alaniz C
    P T; 2010 Sep; 35(9):504-29. PubMed ID: 20975809
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign.
    Casserly B; Gerlach H; Phillips GS; Lemeshow S; Marshall JC; Osborn TM; Levy MM
    Intensive Care Med; 2012 Dec; 38(12):1946-54. PubMed ID: 23064466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies.
    Unar A; Bertolino L; Patauner F; Gallo R; Durante-Mangoni E
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin Alleviates Radiation Proctitis by Regulating Thrombomodulin in Irradiated Endothelial Cells.
    Jang H; Kwak SY; Park S; Kim K; Kim YH; Na J; Kim H; Jang WS; Lee SJ; Kim MJ; Myung JK; Shim S
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32164317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant Therapy in Sepsis. The Importance of Timing.
    Scarlatescu E; Tomescu D; Arama SS
    J Crit Care Med (Targu Mures); 2017 Apr; 3(2):63-69. PubMed ID: 29967873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective on optimizing clinical trials in critical care: how to puzzle out recurrent failures.
    François B; Clavel M; Vignon P; Laterre PF
    J Intensive Care; 2016; 4():67. PubMed ID: 27826449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis.
    Lima CX; Souza DG; Amaral FA; Fagundes CT; Rodrigues IP; Alves-Filho JC; Kosco-Vilbois M; Ferlin W; Shang L; Elson G; Teixeira MM
    PLoS One; 2015; 10(7):e0132336. PubMed ID: 26147469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombomodulin contributes to gamma tocotrienol-mediated lethality protection and hematopoietic cell recovery in irradiated mice.
    Pathak R; Shao L; Ghosh SP; Zhou D; Boerma M; Weiler H; Hauer-Jensen M
    PLoS One; 2015; 10(4):e0122511. PubMed ID: 25860286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of activated protein C for the treatment of sepsis: incorporating observational evidence with a Bayesian approach.
    Zhang Z
    BMJ Open; 2015 Jan; 5(1):e006524. PubMed ID: 25596198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The coagulopathy of acute sepsis.
    Simmons J; Pittet JF
    Curr Opin Anaesthesiol; 2015 Apr; 28(2):227-36. PubMed ID: 25590467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of different anticoagulants on patients with severe sepsis and derangement of coagulation: a protocol for network meta-analysis of randomised controlled trials.
    Jiang L; Jiang S; Feng X; Ma Y; Zhang M
    BMJ Open; 2014 Dec; 4(12):e006770. PubMed ID: 25534216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome.
    Donati A; Damiani E; Botticelli L; Adrario E; Lombrano MR; Domizi R; Marini B; Van Teeffelen JW; Carletti P; Girardis M; Pelaia P; Ince C
    BMC Anesthesiol; 2013 Sep; 13(1):25. PubMed ID: 24070065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.
    Lakhan SE; Kirchgessner A; Tepper D; Leonard A
    Front Neurol; 2013; 4():32. PubMed ID: 23565108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lost in translation? On the effectiveness and efficacy of drotrecogin alfa (recombinant human activated protein C)].
    Gerlach H
    Med Klin Intensivmed Notfmed; 2013 Feb; 108(1):69-70. PubMed ID: 23263456
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating the use of recombinant human activated protein C in adult severe sepsis: results of the Surviving Sepsis Campaign.
    Casserly B; Gerlach H; Phillips GS; Marshall JC; Lemeshow S; Levy MM
    Crit Care Med; 2012 May; 40(5):1417-26. PubMed ID: 22430247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
    Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS
    Crit Care Med; 2010 Apr; 38(4):1101-7. PubMed ID: 20154607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E; Kumar A; Doucette S; Marshall J; Dial S; Gurka D; Dellinger RP; Sharma S; Penner C; Kramer A; Wood K; Ronald J; Kumar A; Turgeon AF; Houston DS; Zarychanski R;
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.